Boothbay Fund Management’s Thermo Fisher Scientific TMO Stock Holding History

Boothbay Fund Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1M	Buy	+2,000	New	+$960K	0.01%	1090
2025 Q4	–	Sell	-7,600	Closed	-$3.69M	–	2369
2025 Q3	$3.69M	Buy	+7,600	New	+$3.54M	0.05%	404
2025 Q1	–	Sell	-8,900	Closed	-$4.63M	–	1785
2024 Q4	$4.63M	Buy	+8,900	New	+$4.89M	0.11%	250
2023 Q1	–	Sell	-5,800	Closed	-$3.19M	–	2495
2022 Q4	$3.19M	Buy	5,800 +5,300	+1,060%	+$2.81M	0.07%	396
2022 Q3	$254K	Sell	500 -500	-50%	-$280K	0.01%	1647
2022 Q2	$543K	Sell	1,000 -1,200	-55%	-$661K	0.01%	1131
2022 Q1	$1.3M	Sell	2,200 -8,100	-79%	-$4.65M	0.03%	773
2021 Q4	$6.87M	Buy	+10,300	New	+$6.43M	0.16%	135

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Boothbay Fund Management's TMO Position: Q2 2026 in Review

Boothbay Fund Management increased its Thermo Fisher Scientific (TMO) stake by 452% in Q2 2026, buying an estimated $3.32M and bringing the position to 8,441 shares worth $4.23M. The position accounts for 0.06% of the portfolio, ranked #405.

Boothbay Fund Management first reported a position in TMO in Q4 2014 and has held it in 32 quarters since. The position peaked at $13.9M in Q4 2024. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Boothbay Fund Management held 8,441 shares of Thermo Fisher Scientific worth $4.23M as of Q2 2026.
Boothbay Fund Management bought 6,913 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.32M.
Thermo Fisher Scientific made up 0.06% of Boothbay Fund Management's portfolio in Q2 2026, its #405 holding.
Boothbay Fund Management first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 32 quarters since.
Boothbay Fund Management's Thermo Fisher Scientific position peaked at $13.9M in Q4 2024.
2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.